PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
11-Jun-2024 Destiny Pharma Awarded Innovation Passport Designation by the UK MHRA for XF-73 Nasal for the Prevention of Post-Surgical Site Infections Destiny Pharma
11-Jun-2024 Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer Thermosome
10-Jun-2024 New blood test could prevent sudden child deaths caused by hereditary heart condition UCL
10-Jun-2024 Ariceum Therapeutics to Present Outstanding New Preclinical Data at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting 2024 Ariceum Therapeutics
10-Jun-2024 FDA approves Almirall’s Klisyri® (tirbanibulin) for the treatment of actinic keratosis on expanded area of face or scalp up to 100 cm2 Almirall’s Klisyri®
10-Jun-2024 New study reveals links between social anxiety, depression and suicidal thoughts in adolescents • University of East Anglia
07-Jun-2024 New US headquarters opened by mass photometry pioneers Refeyn Refeyn
07-Jun-2024 PureTech Result of General Meeting PureTech Health plc
07-Jun-2024 iMM Joins the MAGIC Consortium to Advance Research on Muscular Dystrophies The MAGIC Consortium
07-Jun-2024 16th Edition Strategic Partnerships & Portfolio Optimization for Accessible Medicines, Specialty Therapeutics, and Generic Drugs Conference marcus evans
06-Jun-2024 Major cause of inflammatory bowel disease discovered The Francis Crick Institute
06-Jun-2024 Beckman Coulter Life Sciences Releases Innovative Assay to Quantify Antibody Aggregation Beckman Coulter Life Sciences
06-Jun-2024 Clinigen acquires boutique market access consultancy Ascenian to accelerate access to lifesaving treatments Clinigen
06-Jun-2024 KITE RECEIVES EUROPEAN MEDICINES AGENCY APPROVAL OF SAFETY MONITORING VARIATION FOR CAR T-CELL THERAPY PORTFOLIO Gilead Sciences
06-Jun-2024 Alchemab advances a novel antibody with potential in Parkinson’s disease with support from The Michael J. Fox Foundation Alchemab
06-Jun-2024 CYCLE PHARMACEUTICALS ANNOUNCES ALL-CASH PROPOSAL TO ACQUIRE VANDA PHARMACEUTICALS FOR $8.00 PER SHARE Cycle Pharmaceuticals
06-Jun-2024 FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning CluePoints
05-Jun-2024 OrganaBio expands California CPC Services hub for sample processing and cryopreservation capabilities to support Big Pharma clinical trials OrganaBio
05-Jun-2024 Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year Celerion
05-Jun-2024 Nobel Laureate Professor Sir Martin Evans opens Molecular Devices’ Cardiff facility to manufacture patient-derived organoids for research and drug discovery Molecular Devices, LLC.